Pure Global AI
NCT06298669Suspended

Biventricular Versus Right Ventricular Pacing

Selection of Cardiac Resynchronization Therapy Pacing Modalities in Patients Supported by LVADs
Indiana UniversityClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Heart Failure
Drug/Device/Intervention
Biventricular Pacing
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Indiana University
Location
Indianapolis, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 09, 2023
End date
Feb 01, 2025
Enrollment
28 participants
Primary outcome

6 Minute Walk Test Performance

Summary

The study is a randomized, single-blind crossover prospective study in which investigators
 will determine the clinical outcomes of cardiac resynchronization therapy (CRT) pacing
 modalities in patients with left ventricular assist devices (LVAD). Only patients are
 blinded. This is a small-scale study from which future larger scale randomized controls can
 be performed. The primary endpoint will be the effect of BiV and RV pacing setting on the
 6-minute walk test.

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureLeft ventricular failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06298669
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06298669 through Pure Global AI's free database. This phase not specified trial is sponsored by Indiana University and is currently Suspended. The study focuses on Heart Failure. Target enrollment is 28 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.